BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Fatty acid metabolic process
,
Obesity
,
Lymphocyte
,
Neocentromeres
,
Fluoxetine
,
DRD2
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
ductal carcinoma in situ
Summary
General Info
Curated Studies
Most Correlated Studies
Response to neoadjuvant chemo (5-FU, epirubicin, cyclophosphamide) and resection in breast cancer
Whole tissue breast cancer disease free survival (DFS) profiles after tamoxifen monotherapy
Microdissected breast cancer disease free survival (DFS) profiles after tamoxifen monotherapy
Breast tissues- early neoplasia or invasive ductal carcinoma (DC) or DC in situ compared with normal
Ductal carcinoma in situ, invasive ductal carcinoma, and adjacent normal stromal cells
Explore Curated Studies Results
Literature
Most Relevant Literature
Ductal Carcinoma In Situ.
The role of endocrine treatment on the risk of developing an ipsilateral invasive breast cancer in h…
Breast radiotherapy for non-low-risk ductal carcinoma in situ: to boost or not to boost?
Shifting paradigms for the treatment of ductal carcinoma in situ: Less is more.
Breast radiotherapy for non-low-risk ductal carcinoma in situ: to boost or not to boost? - Authors' …
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Novel Molecular Targets for Ductal Carcinoma In Situ (DCIS)
Tamoxifen or Letrozole in Treating Women With Ductal Carcinoma in Situ
Effects of Diet and Exercise on Ductal Carcinoma in Situ
Contrast-Enhanced MRI for the Characterization of Ductal Carcinoma in Situ (DCIS)
Letrozole in Treating Postmenopausal Women With Ductal Carcinoma in Situ
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ